malignant peripheral nerve sheath tumors
Showing 1 - 11 of 11
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)
Recruiting
- Pediatric Solid Tumor
- +15 more
- Fludarabine
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 30, 2022
Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second
Recruiting
- Pediatric Solid Tumor
- +15 more
- second generation 4-1BBζ EGFR806-EGFRt
- second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
-
Seattle, WashingtonSeattle Children's Hospital
May 2, 2022
Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1 Trial in United States (Selumetinib, Sirolimus)
Active, not recruiting
- Malignant Peripheral Nerve Sheath Tumors
- Neurofibromatosis 1
-
Washington, District of Columbia
- +4 more
Apr 1, 2022
Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)
Active, not recruiting
- Sarcoma
- +10 more
- Hypofractionated radiotherapy
- Hyperthermia
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 27, 2021
Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)
Unknown status
- Sarcoma
- +16 more
- Sequential chemotherapy - 3 courses of AI
- Hypofractionated radiotherapy
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 19, 2021
Malignant Peripheral Nerve Sheath Tumors, MPNST, Sarcoma Trial in United States (everolimus, bevacizumab)
Completed
- Malignant Peripheral Nerve Sheath Tumors
- +2 more
-
Birmingham, Alabama
- +11 more
Feb 13, 2019
Malignant Peripheral Nerve Sheath Tumors Trial in Berlin, Hamburg (imatinib mesylate)
Terminated
- Malignant Peripheral Nerve Sheath Tumors
- imatinib mesylate
-
Berlin, Germany
- +1 more
Aug 6, 2012